Skip to content

Clinical trials

Completed Recurrence trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Status: Completed Country / region: Japan Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20061
20071
20093
20102
20111
20132
20144
20154
20161
20175
20186
20196
20201
20215
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Celgene5
Bristol-Myers Squibb3
Eisai Co., Ltd.3
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan3
Alexion Pharmaceuticals, Inc.2
AstraZeneca2
Janssen Pharmaceutical K.K.2
Mundipharma K.K.2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence47
Multiple Myeloma10
Lymphoma, Large B-Cell, Diffuse5
Brain Ischemia3
Hypercholesterolemia3
Hyperlipidemias3
Ischemic Stroke3
Leukemia, Lymphocytic, Chronic, B-Cell3
Neoplasms3
Stroke3

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.